Evidence map›Paper›PMID 35694189›Full record

ArticleTherapeutic advances in medical oncology2022

Characterizing the

Meredith Li, Faeze Keshavarz-Rahaghi, Gale Ladua, Lucas Swanson, Caroline Speers, Daniel J Renouf, Howard J Lim, Janine M Davies, Sharlene Gill, Heather C Stuart and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in medical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Meredith LiBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Faeze Keshavarz-RahaghiBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Gale LaduaBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Lucas SwansonBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Caroline SpeersBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Daniel J RenoufBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Howard J LimBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Janine M DaviesBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Sharlene GillBC Cancer, The University of British Columbia, Vancouver, BC, Canada.
Heather C StuartVancouver General Hospital, Vancouver, BC, Canada.ORCID https://orcid.org/0000-0003-2806-9184
Stephen YipBC Cancer, The University of British Columbia, Vancouver, BC, Canada.ORCID https://orcid.org/0000-0002-8514-9861
Jonathan M LoreeBC Cancer, The University of British Columbia, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.
University of British Columbia · CAVancouver General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In metastatic colorectal cancer (mCRC), Patients and Methods: This retrospective review evaluated patients in British Columbia, Canada with mCRC and Results: Age at diagnosis, sex, anatomic location and stage at diagnosis did not differ by Conclusion:

Indexed as

cancercolonmetastaticRASrectalsignalling

Identifiers

PMID35694189
PMCPMC9174557
OpenAlexW4285229704

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.